STING1 and breast carcinoma: A recent study has uncovered that TNBC patients that are responsive to chemotherapeutic treatments exhibited increased STING protein expression (Kulasinghe et al., 2021); therefore, further explorations into SIM2 regulation of STING may be beneficial to predict responsiveness to immunotherapeutic treatment for women afflicted with breast cancer.